Absence of intestinal PPARγ aggravates acute infectious colitis in mice through a lipocalin-2-dependent pathway

Parag Kundu1, Teo Wei Ling2, Agata Korecka3

  • 1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden ; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Plos Pathogens
|January 28, 2014
PubMed

Insights

Salmonella Typhimurium causes colitis by inhibiting peroxisome proliferator-activated receptor gamma (PPARγ) and increasing lipocalin-2 (Lcn2). Lcn2 deficiency protects mice from Salmonella-induced colitis.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Host-microbiome homeostasis is crucial for preventing pathogen invasion.
  • Salmonella enterica serovar Typhimurium (S. Typhimurium) disrupts this balance to colonize hosts.

Purpose of the Study:

  • To investigate the mechanism by which S. Typhimurium induces infectious colitis.
  • To identify key host immune factors involved in S. Typhimurium pathogenesis.

Main Methods:

  • Investigated the role of peroxisome proliferator-activated receptor gamma (PPARγ) in S. Typhimurium-induced colitis.
  • Analyzed the expression of innate immune response genes, including lipocalin-2 (Lcn2).
  • Utilized Lcn2-null mice to assess the impact of Lcn2 on colitis severity.

Main Results:

  • S. Typhimurium inhibits PPARγ expression in intestinal epithelial cells, independent of TLR-4 signaling.
  • This inhibition elevates innate immune genes, notably Lcn2, which stabilizes MMP-9 and worsens colitis.
  • Lcn2-null mice showed significantly reduced colitis and protection during S. Typhimurium infection.

Conclusions:

  • S. Typhimurium hijacks host immune gene regulation (PPARγ, Lcn2) for colonization.
  • Lcn2 plays a critical role in exacerbating S. Typhimurium-induced colitis.
  • Targeting Lcn2 may offer a therapeutic strategy against Salmonella infections.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
52